Sun Pharma Q3 Shines: US Sales Strong, Net Profit Jumps 16%
Market
C
CNBC TV18•31-01-2026, 15:04
Sun Pharma Q3 Shines: US Sales Strong, Net Profit Jumps 16%
- •Sun Pharmaceutical Industries Ltd. reported Q3 earnings exceeding Street estimates across all parameters.
- •Net profit surged 16% to ₹3,368.8 crore, surpassing the estimated ₹3,138 crore.
- •Revenue increased 13.5% to ₹15,520.5 crore, also beating Street expectations.
- •US formulation sales reached $477 million, contributing 27.5% to total consolidated sales.
- •The board approved an interim dividend of ₹11 per equity share for FY2026, with a record date of February 5, 2026.
Why It Matters: Sun Pharma delivered a strong Q3 performance with significant profit and revenue growth, exceeding market expectations.
✦
More like this
Loading more articles...
